Rare Diseases and Orphan Drugs

Rare Diseases and Orphan Drugs
Author :
Publisher : Academic Press
Total Pages : 407
Release :
ISBN-10 : 9780124200098
ISBN-13 : 0124200095
Rating : 4/5 (095 Downloads)

Book Synopsis Rare Diseases and Orphan Drugs by : Jules J. Berman

Download or read book Rare Diseases and Orphan Drugs written by Jules J. Berman and published by Academic Press. This book was released on 2014-05-26 with total page 407 pages. Available in PDF, EPUB and Kindle. Book excerpt: Rare Diseases and Orphan Drugs shows that much of what we now know about common diseases has been achieved by studying rare diseases. It proposes that future advances in the prevention, diagnosis, and treatment of common diseases will come as a consequence of our accelerating progress in the field of rare diseases. Understanding the complex steps in the development of common diseases, such as cancer, cardiovascular disease, and metabolic diseases, has proven a difficult problem. Rare diseases, however, are often caused by aberrations of a single gene. In rare diseases, we may study how specific genetic defects can trigger a series of events that lead to the expression of a particular disease. Often, the disease process manifested in a certain rare disease is strikingly similar to the disease process observed in a common disease. This work ties the lessons learned about rare diseases to our understanding of common ones. Chapters covering the number of common diseases are minimized, while rare diseases are introduced as single diseases or as members of diseases classes. After reading this book, readers will appreciate how further research into the rare diseases may lead to new methods for preventing, diagnosing, and treating all diseases, rare or common. - Makes rare diseases relevant to clinicians and researchers by tying lessons learned about the rare diseases to our understanding of the common diseases - Stresses basic pathologic mechanisms that account for human disease (e.g., disorders of cell development, replication, maintenance, function and structure), that can be understood without prior training in pathology - Discusses advanced concepts in molecular biology and genetics in a simple, functional context appropriate for medical trainees and new researchers - Offers insights into how further research into rare diseases may lead to new methods for preventing, diagnosing, and treating all diseases


Rare Diseases and Orphan Drugs Related Books

Rare Diseases and Orphan Drugs
Language: en
Pages: 407
Authors: Jules J. Berman
Categories: Medical
Type: BOOK - Published: 2014-05-26 - Publisher: Academic Press

GET EBOOK

Rare Diseases and Orphan Drugs shows that much of what we now know about common diseases has been achieved by studying rare diseases. It proposes that future ad
Orphan Drugs and Rare Diseases
Language: en
Pages: 487
Authors: David Pryde
Categories: Science
Type: BOOK - Published: 2014-07-30 - Publisher: Royal Society of Chemistry

GET EBOOK

Orphan drugs are designated drug substances that are intended to treat rare or ‘orphan’ diseases. More than 7000 rare diseases are known that collectively a
Rare Diseases and Orphan Products
Language: en
Pages: 442
Authors: Institute of Medicine
Categories: Medical
Type: BOOK - Published: 2011-04-03 - Publisher: National Academies Press

GET EBOOK

Rare diseases collectively affect millions of Americans of all ages, but developing drugs and medical devices to prevent, diagnose, and treat these conditions i
Orphan Drugs
Language: en
Pages: 336
Authors: Elizabeth Hernberg-Ståhl
Categories: Medical
Type: BOOK - Published: 2013-11-15 - Publisher: Elsevier

GET EBOOK

This authoritative and comprehensive book makes the reader familiar with the processes of bringing orphan drugs to the global market. There are between 5,000 an
Rare Disease Drug Development
Language: en
Pages: 418
Authors: Raymond A. Huml
Categories: Medical
Type: BOOK - Published: 2021-11-08 - Publisher: Springer Nature

GET EBOOK

This book provides a broad overview of rare disease drug development. It offers unique insights from various perspectives, including third-party capital provide